On Thursday, June 18, the AAI's 16th Annual Conference, Antitrust and the 2016 Presidential Transition, will undertake an expansive critical examination of the modern antitrust enterprise.
In an article for the South Dakota Law Review, AAI President Diana Moss analyzes competition issues involving transgenic cropseed that are relevant to any Monsanto bid for rival Syngenta.
The AAI filed comments today in regard to slot management and transparency for LaGuardia Airport (LGA), John F. Kennedy International Airport (JFK), and Newark Liberty International Airport in response to a Notice of Proposed Rulemaking by the U.S. Department of Transportation and Federal Aviation Administration. The AAI comments highlight the NPRM proposals that are likely to have beneficial effects on entry, competition, and efficiency while providing important context regarding competition in the U.S. airline industry for the purposes of evaluating the proposals in the NPRM. The AAI also offers suggestions in various areas where the NPRM proposals could be refined to better achieve the FAA's procompetitive goals.
As advocated by the American Antitrust Institute (AAI), the California Supreme Court issued a ruling on May 7 adopting a “structured” rule of reason favorable to plaintiffs litigating the lawfulness of pharmaceutical reverse-payment settlements under California law.
“This is an important victory for consumers in the battle over reverse-payment settlements and should have positive implications for cases brought under federal antitrust law,” said the AAI Vice President and General Counsel Richard Brunell.
Donald I. Baker will receive the AAI Alfred E. Kahn Award for Antitrust Achievement at the American Antitrust Institute's Annual Conference on June 18.
Mr. Baker is founding partner of the independent Washington D.C. law firm Baker & Miller PLLC, specializing in antitrust, competition policy and international law issues. Mr. Baker¹s efforts have included comprehensive aspects of antitrust counseling, representing complainants, as well as targets in various government investigations, corporate internal investigations, major arbitrations, and several private antitrust cases for plaintiffs and defendants.